AI and IoT-Enhanced Skin Cancer Detection and Care (Part 2)

The rising incidence of skin cancer worldwide underscores the critical need for effective early detection methods. Mobile health applications (mHealth apps) have recently emerged as promising methods for enhancing self-examination and improving early diagnosis, equipping individuals to observe skin lesions and identify aberrant modifications in the comfort of their homes. This chapter discusses the purpose of mHealth apps for skin cancer detection and the historical development of skin cancer detection technologies based on AI and machine learning (ML) and hyperspectral imaging. These technologies and non-invasive techniques are transforming the landscape of skin cancer screening by making it more accessible and efficient. It also describes the functioning of mobile-based applications to perform self-examination, including image capture and analysis, guided self-assessment, and compatibility with healthcare providers. These apps also provide educational materials on skin cancer awareness and prevention. Key mHealth apps, such as Derma Compare, Lubax, SkinVision, and Doctor Mole, are discussed in detail in terms of their functionality and contribution towards skin cancer detection. In addition, this chapter evaluates the effect of these mobile applications on health. It discusses whether they can reduce healthcare costs, improve population health outcomes, and be embedded into current healthcare systems. It also covers the barriers to access and the necessity for continuous postmarket surveillance. Finally, future research directions are proposed to enhance the precision, accessibility, and implementation ability of these technologies to ensure their continued utility in skin cancer detection.

Skin cancer is one of the most common forms of cancer found in human beings around the world and is a major hurdle to health systems due to its high frequency and difficult diagnosis. While early and accurate detection is key for better patient outcomes, traditional methods depend heavily on the clinical expertise of individual physicians. Recent developments in artificial intelligence (AI), especially deep learning (DL) and transfer learning (TL), present new, powerful methods for improving the detection of skin lesions. In this chapter, DL algorithms such as convolutional neural networks (CNNs) were applied, with operations leveled up concerning TL, where pre-trained models are leveraged for accurate diagnosis, along with overcoming important issues like scarcity of annotated datasets and inconsistency in dermoscopic images. This redundancy also hinders the development of model training with small, domain-specific datasets, which is why TL can overcome many common bottlenecks of medical images. We review the incorporation of AI-enabled systems into clinical workflows, the efficacy of deep learning models in the detection of different skin cancer types, and the capacity of such technologies to augment dermatologic serendipity. This chapter offers perspectives on research needs, such as hybrid models combining AI and non-AI data, the integration of ethnic and structural racism in AI systems in healthcare, as well as a need to centralize current AI ethics literature in the healthcare field. We aim to utilize DL and TL to assist in the early detection of skin cancer that can redirect to more targeted treatment approaches.

Skin cancer is the most common type of cancer, whereby genomic alterations contribute to both its pathogenesis and evolution as well as its response to treatment. Genomic diagnostics play a crucial role in aiding the precise management of skin cancers based on the detection of mutations or genomic alterations that guide targeted treatment. The chapter outlines the clinical presentation of these skin cancers and their genomic landscape, highlighting important genotype-specific alterations such as BRAE NRAS and CDKN2A mutations in melanoma, PTCH1, SMO, and TP53 mutations in BCC and HRAS, NOTCH1, and combined gene inactivation in SCC. It also reviews copy number variations (CNVs) closely related to the development of different skin cancers. The area of genomic profiling has advanced over the years, with techniques such as next-generation sequencing (NGS), liquid biopsies, and targeted gene panels that are able to provide a comprehensive look into informative genetic alterations non-invasively. The technologies allow for early detection, quantitating response to systemic therapy, and uncovering mechanisms of resistance, which altogether can promote better therapeutic success. Genomic diagnostics play a pivotal role in the treatment of personalized strategies based on genome markers; nowadays, doctors can make therapies according to genetic profiles. Molecular profiling enhances early detection and diagnosis, which results in timely interventions and better prognoses. By sequencing treatment response and resistance mechanisms, we gain realtime insight into the evolution of tumor behavior and can develop adaptive therapeutic strategies that respond to those changes. Genomic diagnostics have an important role to play both in risk assessment and prognosis of diseases by detecting the presence or absence of genetic markers associated with aggressive behavior, which can then be used to classify patients according to their risk profile.

5G is believed to revolutionize telemedicine and dermatology in this regard by enhancing real-time consultations and the accuracy of diagnosis. 5G can offer faster connectivity and lower latencies than 4G, which is vital in telehealth and remote diagnostics. This also helps establish real-time interactive communication between patients and doctors for faster consultations and remote collaboration amongst multidisciplinary teams. The benefit of 5G is the ability to send clearer images, which enables dermatologists to analyze skin problems better. With AI integration, real-time data processing further enhances diagnostic capabilities by allowing for more specific and faster assessments. Telehealth gains new ground through the expansion of 5G, which can benefit rural and underserved populations by enabling patients to avoid travel time or costs. Wearable devices and IoT-enabled sensors can be used in dermatology to monitor skin conditions in real-time digitally; tracking and managing chronic skin diseases remotely is possible. Video consultations aid in increasing patient engagement via education and adherence to treatment plans. At the same time, emerging technologies such as augmented reality (AR) or virtual reality (VR) are being integrated into treatment/education for patients. Telemedicine can leverage 5G for new skin monitoring, diagnosis, and personalized care through real-time image transmission. Updated 5G infrastructure is forthcoming and will certainly impact the future of dermatology, access, equity, and care quality. 

This chapter explores the vital importance of embedding community engagement in the planning and execution of successful skin cancer prevention initiatives. It highlights the need for collaborative action among community members, local organizations, healthcare providers, and local and state policymakers to fight the growing incidence of skin cancer. This chapter explains that increasing community engagement may include focused outreach programs, culturally adapted education, and free resources such as skin screening and sun protectants. It explores challenges to successful engagement, including poor recognition of UV risks, cultural norms about tanning behaviors, and access to preventive services, and represents an opportunity to advance solutions. By examining effective examples and evidence-informed approaches, the chapter offers guidance on the role of inclusivity and responsiveness to community needs in policy and practice to facilitate the uptake of sun-safe behaviors. Finally, it identifies some future directions for community participation, suggesting that innovative, flexible, and participatory approaches to health promotion could leverage technology and aid in collaboration among individuals at risk of skin cancer and in the identification of skin cancer prevention advocates, which may help empower individuals and communities to take more responsibility for their skin health. This chapter ultimately seeks to motivate a proactive rather than a passive collaborative model for preventing skin cancer, recognizing that all of us must work together to reduce this preventable disease.

Personalized treatment plans are becoming the norm in modern healthcare, with AI-driven decision support systems creating the optimal care paths based on individual patient needs. Artificial intelligence technologies like Machine learning, Natural language processing (NLP), Predictive analytics, and reinforcement learning utilize diverse data sources, such as electronic health records (EHRs), data from wearable devices, and genetic profiles. AI can use real-time and historical data to provide customized treatments, follow up on progress, and dynamically update care plans, delivering more specific and accurate solutions. With fewer trial-and-error-based processes, the capacity of AI to assist decision-making translates to improved patient outcomes through targeted therapies and support for accurate diagnosis. Realizing these benefits, however, necessitates addressing data privacy, the ethics of large language models, and the risks of biases embedded in AI models. Building trust around these systems requires transparency, explainability, and compliance with regulatory standards (HIPAA, GDPR). Although AI holds immense potential to enhance patient engagement and operational efficiency, integrating extensive data and acceptability among clinicians still holds back its benefits. However, with the advancements in AI technologies, there is hope for real-time, adaptive treatment adjustments and improved collaboration between AI systems and healthcare professionals. AI-based systems are ready to revolutionize personalized healthcare, turning optimal, tailored treatment pathways from an idea into a reality in multiple patient cohorts.

The most significant dangers of sun exposure to skin health are skin cancer, sunburn, and premature aging. Addressing these risks requires effective early intervention and prevention strategies. New technologies, particularly Artificial Intelligence (AI) and the Internet of Things (IoT), are changing how we interact with and protect ourselves from the dangers of the sun. AI technology provides an in-depth assessment of skin health and calculates individual risk through predictive modeling of UV exposure, thus providing personalized recommendations for sun protection. AIbased solutions allow for customization of interventions to individual needs, leading to better effectiveness and adherence. Sun exposure can be managed through real-time monitoring of UV levels using IoT devices. Smart bands and UV sensors integrated into smart clothing and accessories with inherent SPF provide real-time sun exposure feedback. Mobile app integration improves engagement and ensures timely protection against sun damage. Risk management is primarily based on data-driven insights. AI and IoT data allow one to track long-term sun exposure and calculate a risk assessment based on how sun rays damage their skin over this long period. High-performance cloud-based platforms allow for full storage and analytics of the data, but these must be secured against privacy and security concerns. By leveraging gamification, awareness campaigns, or community-based apps, AI and IoT technologies can improve public knowledge and comprehension by making sun protection habits more tangible. These technologies provide benefits but face many challenges, including technical limitations, high costs, privacy issues, and ethical concerns. The future trends involve new AI algorithms and IoT space innovations for enhanced UV detection and skin health monitoring. Such developments can lead to major advancements in global skin cancer preventative strategies and public health outcomes.

Remote Patient Monitoring (RPM) has evolved into an influential modality within the field of dermatology, aiding in both treatment compliance engagement and early detection of skin cancer. RPM technologies have emerged as a critical modality in these efforts, including artificial intelligence (AI) and machine learning (ML), and smartphone applications for skin monitoring, screening, and treatment of melanoma. This chapter explores the importance of RPM in treatment compliance and engagement and how effectively aligned patient engagement strategies contribute to adherence monitoring with a compliant clinical treatment regimen. Teledermoscopy is among the most important fields of RPM, and it allows the diagnosis and monitoring of skin lesions remotely through a smartphone with an accuracy equivalent to that of conventional visits. This highlights the significance of early detection of skin cancer, portraying how RPM can help in making timely interventions that lead to better patient outcomes. The most prominent benefits of RPM for skin cancer patients are increased communication between patients and providers, more access to specialized dermatological care, and overall improved satisfaction with the treatment process. The chapter identifies challenges and limitations as well, including technology obstacles, difficulties in data integration, patient privacy issues, and the necessity for enhancing patients' digital health literacy. The chapter concludes by contemplating the future of RPM for skin cancer monitoring, including new imaging technology trends, potential expansion into preventive dermatology, and policy/regulatory challenges that must be addressed to facilitate broader adoption of RPM. This chapter identifies these elements to guide an understanding of how RPM can assist treatment adherence and early detection of skin cancer.